At present, olverembatinib has been approved in China for the treatment of adult patients with TKI-resistant chronic-phase chronic myeloid leukemia (CML-CP) or accelerated-phase CML (CML-AP) harboring ...

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.

Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Free Report) has been assigned an average rating of “Buy” from the five brokerages that are currently covering the firm, Marketbeat reports. Four equities ...

News on Inhibikase's promising treatments for PAH and Parkinson's Disease, supported by FDA approval and substantial funding.

If he could somehow target the mutant protein ... Novartis produced a compound known as imatinib that worked in the test tube. It worked in mice. It worked in rats. But would it work in humans?

Target will be closed on Thanksgiving for the fifth year in a row, however stores will open early on Black Friday and stores will have extended hours for several weeks starting Nov. 30, the ...

Chronic myeloid leukaemia (CML) blockbuster Gleevec has been badly hit by generic competition in the US, revenues falling 30% to $834 million in the period. This decline will continue, with ...

Prithviraj Bose, MD, discusses the most critical adverse effects seen with each of the 4 approved JAK inhibitors for the treatment of myeloproliferative neoplasms. Prithviraj Bose, MD, professor in ...